Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267592
Status:
COMPLETED
Last Update Posted:
2016-05-19
First Post:
2005-12-19
Brief Title:
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Glioblastoma Multiforme |
Keywords: